Key Insights

Highlights

Treatment Research

2 treatments under study, led by Active Comparator 1

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07393334Phase 2Recruiting

Effects of NLS-133, a Potential Non-Hormonal "On-Demand" Male Contraceptive

Showing all 1 trials

Research Network

Common Treatments

  • Active Comparator 11
  • Nls1331

Active Sponsors

  • Next Life Sciences1

Related Conditions

  • Sperm Motility1
  • Male Contraception1

Activity Timeline